Cite
HARVARD Citation
Palace, J. et al. (n.d.). Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator. Lancet neurology. 14 (5), pp. 497-505. [Online].